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The glutathione/cysteine exporter CydDC maintains redox
balance in Escherichia coli. A cydD mutant strain was
used to probe the influence of CydDC upon reduced thiol
export, gene expression, metabolic perturbations, intracellular
pH homoeostasis and tolerance to nitric oxide (NO). Loss
of CydDC was found to decrease extracytoplasmic thiol
levels, whereas overexpression diminished the cytoplasmic
thiol content. Transcriptomic analysis revealed a dramatic
up-regulation of protein chaperones, protein degradation (via
phenylpropionate/phenylacetate catabolism), β-oxidation of fatty
acids and genes involved in nitrate/nitrite reduction. 1H NMR
metabolomics revealed elevated methionine and betaine and
diminished acetate and NAD+ in cydD cells, which was consistent
with the transcriptomics-based metabolic model. The growth rate
and pH, however, were unaffected, although the cydD strain did
exhibit sensitivity to the NO-releasing compound NOC-12. These
observations are consistent with the hypothesis that the loss of
CydDC-mediated reductant export promotes protein misfolding,
adaptations to energy metabolism and sensitivity to NO. The
addition of both glutathione and cysteine to the medium was found
to complement the loss of bd-type cytochrome synthesis in a cydD
strain (a key component of the pleiotropic cydDC phenotype),
providing the first direct evidence that CydDC substrates are
able to restore the correct assembly of this respiratory oxidase.
These data provide an insight into the metabolic flexibility of E.
coli, highlight the importance of bacterial redox homoeostasis
during nitrosative stress, and report for the first time the ability
of periplasmic low molecular weight thiols to restore haem
incorporation into a cytochrome complex.
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INTRODUCTION
Early phenotyping of Escherichia coli cydDC mutants reported
that this locus was required for the correct assembly of cytochrome
bd-type quinol oxidases [1,2]. Based both on the observed gene
structure and deduced protein sequences, CydDC was postulated
to form a heterodimeric ABC transporter with two transmembrane
domains, each comprising six α-helices, and two nucleotide
binding domains [3]. The periplasm of strains lacking a functional
CydDC were reported to be ‘over-oxidized’ [4], and subsequent
functional characterization revealed that CydDC exports both
reduced glutathione (GSH) [5] and cysteine [6] to the periplasm.
The phenotype of the cydD mutant strain is pleiotropic,
exhibiting sensitivity to benzylpenicillin and dithiothreitol, loss
of motility and the absence of holocytochrome c. These
characteristics are reminiscent of E. coli dsb mutants [7],
implicating defective disulfide bond formation/isomerization in
the manifestation of these traits in cydDC mutant strains.
These phenotypes, together with the loss of periplasmic
cytochrome b562 (a typical cydDC phenotype), can all be
corrected by the addition of cysteine or GSH to the growth
medium [5,6,8], although the addition of GSH or cysteine
alone cannot restore the assembly of bd-type quinol oxidases
[5,6]. These observations point towards a role for CydDC in
maintaining the periplasm at an optimum redox poise that
is required for correct disulfide bond formation, and for the
incorporation of haem cofactors into respiratory complexes and
periplasmic hemoproteins. The involvement of CydDC-mediated
glutathione/cysteine translocation in hemoprotein assembly is
supported by the observation that CydDC overexpression under
anaerobic conditions leads to the accumulation of a novel
haem compound P-574 associated with the inner membrane [9].
Additionally, anaerobically grown E. coli overexpressing CydDC
was found to contain a haem-bound form of NikA, a periplasmic
nickel chaperone [10]. More recently, electron cryomicroscopy
has confirmed a heterodimeric structure for CydDC, spectroscopic
analyses reveal that haem b is bound to the purified complex, and
kinetic assays demonstrate a stimulation of ATPase activity upon
addition of haem and various thiol compounds [11]. Although
assigning a role for haem transport is tempting for CydDC,
previous investigations indicate that this is not a physiological
role for this transporter [12], indicating a likely role for the haem
cofactor in redox sensing.
Clearly, the contribution of CydDC to the maintenance of
redox homoeostasis has an intricate relationship with cellular
metabolism. Herein, we probe the response of E. coli to changing
internal redox poise through the transcriptomic and physiological
analysis of a cydD mutant strain.
EXPERIMENTAL PROCEDURES
Bacterial strains and growth conditions
The bacterial strains used in this work are from the Keio collection
[13]. The wild-type strain and the isogenic cydD strain have a
BW25113 [14] background. Starter cultures (10 ml) were grown
Abbreviations: GSH, reduced glutathione; NO, nitric oxide; TrxB, thioredoxin reductase.
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to stationary phase in LB, and 0.5 ml was used to inoculate 50 ml
of defined medium [15] supplemented with 0.1% (w/v) casamino
acids. For the microarray experiments, cells were grown in 250 ml
Klett flasks (sidearm) at 37 ◦C and 180 rpm in triplicate, and
culture turbidities were measured in Klett flasks using a Klett-
Summerson colorimeter (red filter). Kanamycin (50 μg/ml) was
included where appropriate, and glycerol (54 mM) was used as
a carbon source. A typical cydD phenotype, the absence of a
cytochrome d spectroscopic signal [2], was confirmed for the
BW25113-cydD strain. For the growth curves in the presence of
nitric oxide (NO)-releasing compounds, a Fluostar Omega plate
reader (BMG Labtech) was used to measure OD600 for at least four
repeats of each condition. The same growth medium was used
as above, and NOC-12 was dissolved in sterile 80 mM sodium
phosphate buffer (pH 8.0) immediately before use and added to
the microplate wells at the time of inoculation. Growth rates were
calculated from 2 h after the end of the lag phase for the [NOC-
12] = 0 data, which was defined as the intercept on the time axis
created by the regression line for the maximal growth rate.
Whole-cell absorption spectroscopy
To generate microaerobic conditions that enhance the assembly
of bd-type cytochromes, E. coli cultures (100 ml) were grown
overnight in LB medium in 250 ml conical flasks at 37 ◦C and
150 rpm. Cells were harvested and CO-difference spectra were
recorded on whole cells as previously described [16].
Quantification of reduced thiol concentration
Cells were grown exactly as for the microarray experiments and
growth medium was isolated from exponentially-growing cells via
centrifugation of cultures (2342 g, 4 ◦C, 10 min). Spheroplasts
were prepared using a modified osmotic shock procedure [17].
In brief, 5 ml of exponentially-growing cells were conditioned
for osmotic shock via addition of NaCl and Tris/HCl buffer
(pH 7.3) to give final concentrations of 27 mM each. Cells
were harvested (2342 g, 20 min, 20 ◦C), suspended in 35 μl
of supernatant from the first centrifugation and supplemented
with 35 μl of a 40% (w/v) sucrose solution containing 33 mM
Tris/HCl pH 7.3 and 2 mM EDTA. The cell suspension was
then incubated at room temperature (20 min) and harvested by
centrifugation (3024 g, 20 min 20 ◦C). Cells were then suspended
in ice cold water (250 μl) and left on ice for 45 s before
MgCl2 was added (final concentration 1 mM). After incubation
on ice for 10 min, centrifugation (4355 g, 10 min) at 4 ◦C gave
a supernatant periplasmic fraction and a pellet of spheroplasts
that was suspended in 1 ml of 80 mM sodium phosphate buffer
(pH 8.0) and used for reduced thiol quantification.
DTNB assays were used to quantify the reduced thiol content
of growth medium and spheroplasts using a modified version of
Ellman’s assay [18]. In brief, 1 ml assays included 100–200 μl
of sample, 50 mM sodium phosphate buffer (pH 8.0), 0.3 mM
DTNB, 1.3 mM EDTA, 2% SDS (w/v). Assays were incubated at
room temperature (2 min) and absorption spectra were recorded.
Reduced thiol concentrations were calculated using A412–500 (to
normalize for baseline shifts) using an absorption coefficient for
TNB of ε412 = 14.15 mM− 1·cm− 1 [19].
Microarray analysis
Aliquots (30 ml) were taken from batch-grown cultures of
E. coli during mid-exponential growth (OD600 = 0.4), and
immediately transferred to RNAprotect (Qiagen). RNA was
isolated using Qiagen RNeasy mini kits, and cDNA preparation
and microarray analyses were performed as previously described
[15]. The slides used were E. coli K12 arrays purchased from
Ocimum Biosolutions. These slides contain 4288 gene-specific
oligonucleotide probes representing the complete E. coli genome.
The slides were scanned using an Affymetrix 428 array scanner.
The average signal intensities and background corrections were
performed using Imagene and Genesight software (Biodiscovery)
and the mean fluorescence values were log2 transformed and
normalized using the LOWESS method. The Cy5/Cy3 ratios were
calculated from the normalized values. Biological experiments
(i.e. cydD compared with wild-type comparison) were carried out
twice, and dye-swap analysis was performed on each experiment,
providing four technical repeats, two from each biological
experiment. Data from independent experiments were combined,
and genes differentially regulated 2-fold and displaying a P-
value of 0.05 (using t-test) were defined as being statistically
differentially transcribed.
Modelling transcription factor activities
Transcriptomic data were analysed using a probabilistic model of
global transcriptional regulation [20]. The model adopts a log-
linear approximation to the transcriptional reaction to changes
in transcription factor activity, which can be thought of as a
first order approximation to more general forms of non-linear
transcriptional response. Changes in gene expression are modelled
as a weighted linear combination of changes in transcription factor
activity according to
yn =
∑
m
Xnmbnmcm + εn
Here, Yn is the log-fold change for the nth gene, Xnm a
binary matrix encoding the structure of the regulatory network
(obtained from the literature), bnm the unknown rate constants
for activation/repression, cm the (log) change in transcription
factor activity and εn an error term. Both the rate constants
and the transcription factor activity changes are given zero mean
normal priors. By using a variational approximation, the inference
problem can be approximately solved, providing estimates of
the changes in activity of regulators (with error bars) from an
analysis of the behaviour of their targets. This technique has been
applied to reconstructing the regulatory response in E. coli to
the transition between aerobic and microaerobic conditions [21],
and to the response to CO-releasing molecules [22]. To provide a
computational control experiment, the results of the inference can
be compared with multiple analyses performed on randomized
networks as previously performed in [21,22].
1H NMR metabolomics
Cells were grown as described for the microarray experiments
(five repeats for each strain) and cells were harvested at an OD600
of 0.4 from 30 ml aliquots by centrifugation (4355 g, 5 min, 4 ◦C).
Pellets were washed three times with 1 ml of ice-cold PBS, and
cells were then snap frozen in liquid nitrogen and stored at −80 ◦C
for metabolite extraction. Frozen samples were homogenized
in 600 μl ice-cold acetonitrile buffer extraction solution [50%
acetonitrile (v/v), 50 mM NaH2PO4/K2HPO4 buffer pH 7.4].
Homogenates were then snap frozen in liquid nitrogen and
subjected to three rounds of freeze–thaw cycles with vigorous
pipetting and vortex-mixing. Samples were then sonicated on ice
for 99 × 2 s with 2 s intervals. Sonicated samples were centrifuged
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(17418 g, 10 min, 4 ◦C) and the supernatant decanted. The
remaining pellet was suspended in 500 μl acetonitrile extraction
solution and vortex-mixed for further metabolite extraction, and
the resultant supernatant was pooled with that from the first
extraction. The supernatants were placed in a vacuum desiccator
to remove acetonitrile extraction solution, and samples were then
stored at −80 ◦C.
Frozen metabolite pellets were defrosted and then dissolved in
a mixture of 600 μl deuterated water (2H2O) containing 100 μM
TSP (trimethylsilyl propionate, sodium salt), which was included
as an internal standard for both chemical shift referencing and
quantification. After centrifugation (18110 g, 2 min, 4 ◦C) to clear
any debris, 550 μl of this mixture was pipetted into NMR tubes
(5 mm outer diameter) for 1H NMR spectroscopy. 1H NMR data
were recorded using the noesypresat pulse sequence at 25 ◦C using
a Bruker Avance III 600 MHz NMR spectrometer equipped with a
QCI-F cryoprobe. Data were recorded with 64k points, 512 scans
and a spectral width of 9591 Hz. An acquisition time of 3.42 s
and a relaxation delay of 3.0 s were used. This provided an overall
recycle time between pulses of 6.42 s. Areas beneath peaks were
integrated to provide a measure of metabolite abundance.
Determination of pH
For the determination of pH, exponentially growing cells were
used. In these experiments, cells (3 × 1 ml samples) were taken
directly from the growing culture and added to a glass tube
containing [7-14C]benzoate (11 μM, pKa = 4.2, Life Science
Products). [14C]Polyethylene glycol (33 μM, Amersham) and
[3H]water (1 mM, Life Science Products) were used to determine
intracellular volume. After incubation for 5 min at 37◦C with
aeration, the cultures were centrifuged through 0.35 ml silicon
oil (BDH Laboratory Supplies) in 1.5 ml microcentrifuge tubes
(13000 g, 5 min, 22◦C) and 20 μl samples of supernatant were
removed. The tubes and contents were frozen (−20◦C), and cell
pellets removed with dog nail clippers. Supernatant and
cell pellets were dissolved in scintillation fluid and counted
using a 1214 Rackbeta liquid scintillation counter (LKB Wallac,
[14C]-window). The silicon oil mix was a 40% (v/v) mixture
of phthalic acid bis(2-ethyl-hexyl ester) and 60% (v/v) silicone
oil (40% part mixture of DC200/200 silicone oil and 60%
DC 550). The intracellular volume (2.8 +− 0.5 μl mg·protein− 1)
was estimated from the difference between the partitioning of
3H2O and [14C]polyethylene glycol. The pH was determined
from the distribution of [14C]benzoate using the Henderson–
Hasselbalch equation [23], and ZpH was calculated as 62 mV ×
pH. Protein from NaOH-hydrolysed cells (0.2 M NaOH, 100◦C,
20 min) was assayed by the method of Markwell et al. [24].
RESULTS
CydDC decreases reduced thiol content in the cytoplasm and
elevates extracellular reduced thiols
It has previously been reported that loss of cydD results in an
over-oxidising periplasm in stationary phase cultures [25]. To
provide a measure of CydDC-mediated thiol export in growth
cultures relevant to the current study, DTNB assays were carried
out. Exponentially-growing wild-type, cydD and complemented
cydD cells were grown in defined medium and the reduced
thiol concentrations of the growth medium and spheroplast
preparations were measured (Figure 1) to provide a measure
of how CydDC affects redox balance across the cytoplasmic
membrane (reproducible measurements from the periplasm could
not be recorded as previously reported for exponentially growing
Figure 1 Influence of CydDC upon extracellular and intracellular reduced
thiol concentrations
DTNB assays were used to quantify extracytoplasmic and cytoplasmic reduced thiol levels when
CydDC expression was varied. Wild-type and cydD mutant strains were grown along with a
cydD strain complemented with the pRKP1602 vector encoding cydDC downstream of the native
promoter [9]. The average OD600 values at which cells were harvested were all within the range
0.37–0.39. The concentrations of reduced thiols in growth medium (black bars) and spheroplasts
(white bars) correspond to the left hand and right hand axes, respectively. Mean values of three
repeats with error bars showing S.D. are shown, and t tests demonstrate significant differences
between indicated datasets at the 99 % (**) and 99.9 % (***) levels.
cells [25]). Predictably, loss of cydDC significantly diminished
the reduced thiol concentration in the growth medium (black
bars), a phenotype which was complemented by the presence
of the cydDC complementation plasmid pRKP1602. Loss of
cydDC did not increase the intracellular thiol content as initially
predicted, but overexpression of CydDC through the presence
of the high copy number plasmid pRKP1602 significantly
depleted the intracellular concentration of reduced thiols (white
bars). Together, these data confirm that CydDC does indeed export
reduced thiols, but cydD cells are able to compensate for this loss
of export function in terms of maintaining wild-type levels of
intracellular thiols.
Global transcriptional responses to the loss of cydD
To investigate the adaptations of E. coli that compensate for the
loss of CydDC-mediated reductant export during exponential
growth, a cydD vs. wild type microarray comparison was
performed. Cells were harvested during mid-exponential phase,
when both wild-type and cydD strains were dividing at a similar
rate. Labelled cDNAs were synthesized and used to probe
E. coli K12 arrays (Ocimum Biosolutions). For preliminary
analysis of the data, a significant change was defined as 2-
fold and displaying a P-value of 0.05. Loss of CydDC elicits
a pleiotropic phenotype, so predictably, the current microarray
comparison identifies a large number of differentially transcribed
genes in cydD cells. A total of 97 genes were significantly
up-regulated, and 41 genes were significantly down-regulated
(Supplementary Table S1). The majority of the up-regulated
genes are involved in protein degradation, β-oxidation of
fatty acids and respiratory adaptations, whereas many of the
down-regulated genes are involved in nucleotide metabolism,
motility and sulfate/thiosulfate transport. To create a model
for the impact of these transcriptional changes upon E. coli
physiology, selected genes were mapped on to a metabolic
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Figure 2 Model for the adaptations of a cydD strain
The gene transcript levels and transcription factor activities that are up- and down-regulated in the current cydD compared with wild-type transcriptomics are shown in red and blue, respectively.
The brown and cyan lines denote processes that are predicted to be up- and down-regulated, respectively. Metabolites that were analysed via 1H NMR are highlighted in indigo (discussed later on).
Abbreviations: Ac-CoA, acetyl CoA; Gor, glutathione oxidoreductase; Grx, glutaredoxin; GSSG, glutathione disulfide; LMT, low molecular weight thiol.
diagram (Figure 2). All the genes in Figure 2 were confirmed
to be differentially regulated with an independent microarray
study (Supplementary Table S2). Together, these data illustrate
that loss of CydDC-mediated glutathione/cysteine export elicits
the up-regulation of several genes involved in the catabolism of
phenylacetate and phenylpropionate, fermentation end products
of gut bacteria [26] and intermediary compounds produced during
protein degradation [27,28]. Since a large number of protein
chaperones and proteases are up-regulated in the cydD strain
(Figure 2), it seems likely that misfolded protein is broken down
to succinyl-CoA and pyruvate is fed into the Krebs cycle for the
generation of NADH. Furthermore, given the inability of cydD
cells to synthesize cytochrome bd-type quinol oxidases [13], it
is intriguing that the NapGH and NapAB complexes are up-
regulated in the current work: NapGH channels electrons from
ubiquinol to the NapAB nitrate reductase [29,30], the preferred
electron acceptor under conditions of diminished oxygen.
Transcription factor modelling
To gain an understanding of the major regulatory mechanisms
that underpin the transcriptomic changes observed herein,
probabilistic modelling was performed to highlight those
transcription factors that are predicted to exhibit perturbed
activities in a cydD strain compared to wild-type. This facilitated
the identification of physiological and/or regulatory stimuli that
underpin the changes in expression. Based on preliminary regulon
analysis of the differentially regulated genes, it was hypothesized
that the following regulators exhibit different activities in cydD
and wild-type cells: ArgR, BetI, CaiF, CRP, CysB, FadR, Fis,
FlhDC, FNR, FruR, Fur, GadE, GlcC, HcaR, IHF, MhpR,
NarL, NarP, OxyR, PurR, OxyS, SoxR and SoxS. Probabilistic
modelling was performed for these transcription factors, nine of
which displayed a significant difference in activity between cydD
and wild-type cells. Figure 3 shows the predicted activities of
the regulators that were found to elicit significant transcriptional
changes, and Figure 4 shows the genes under the control of these
regulators. Together, these data demonstrate that FlhDC, GlcC,
HcaR, MhpR, NarP and PurR activities are enhanced, and BetI,
CysB and FadR activities are diminished. Using a previously
described procedure [21,22] we can conclude that the probability
of obtaining as many as nine regulators responding to a stimulus
is negligible (<0.001), indicating that a clear pattern of regulation
can be confidently extracted from the data. The major functional
categories of genes affected are described below.
The most striking transcriptomic adaptations are elicited by
the FlhDC and NarP regulators (Figure 4), where several genes
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Figure 3 Theoretical transcription factor activities arising from cydD
deletion
The inferred activities arise from the term cm(t ) in the model [20]. The error bars represent the
S.D. provided by the posterior distribution.
involved in nitrate and nitrite reduction are up-regulated: NapAB
is a high affinity periplasmic nitrate reductase, important for
anaerobic growth under nitrate-limiting conditions [31], and
NapGH is a membrane-associated complex required to channel
electrons from ubiquinol to NapAB [29,30]. Additionally, the
nitrite reductases encoded by nrf and nir operons are also up-
regulated: nrf and nir are important for anaerobic growth when
nitrite is limiting or in excess, respectively [32]. In addition, nitrate
reductase 1-encoding narG is also up-regulated (Supplementary
Table S1).
Genes controlled by MhpR and HcaR are up-regulated in cydD
cells (Supplementary Table S1). These positive regulators of
phenylpropionate catabolism are activated by phenylpropionate
[33] and are repressed by glucose [27]. Given that these
pathways are intermediates in protein degradation [27,28], and
that several chaperones and proteases are up-regulated in cydD
cells (Figure 2), it is hypothesized that misfolded proteins
resulting from reducing conditions in cydD cells are broken down
via phenylpropionate and phenylacetate to pyruvate and succinyl-
CoA, respectively (Figure 2).
Several genes involved in the breakdown of glycolate and
glyoxylate are down-regulated in cydD cells (Supplementary
Table S1), and the modelling data are consistent with elevated
activity of the positive regulator GlcC (Figure 3). In addition,
genes involved in thiosulfate/sulfate transport, sulfite metabolism
and purine biosynthesis are down-regulated in cydD cells.
Together, the transcriptomic and modelling data demonstrate
that a diminished activity of the CysB transcriptomic activator
and a diminished activity of the PurR repressor are largely
responsible for these changes in gene expression (Figures 3
and 4). Additionally, the current data demonstrate that the BetI
transcriptional regulator is inducing genes that encode members
of the glycine betaine pathway involved in osmoprotection in E.
coli [34].
Deletion of cydD perturbs metabolite concentrations
To gain further insights into the adaptations of cydD cells that may
contribute to the response to redox stress in cydD cells, 1H NMR
spectroscopy was used to quantify a variety of metabolites. The 1H
NMR spectra of metabolites extracted from wild-type and cydD
cells were analysed manually to identify variations in metabolite
abundance. To assign NMR peaks to metabolites the ‘Madison
Metabolite Consortium Database’ [35] was used. Peaks that were
hypothesized to vary between the wild-type and cydD data
were assigned to signature peaks for specific metabolites, and
then all spectral features of the metabolites were confirmed to
vary by the same magnitude between the wild-type and cydD
data. Integrated peak areas were averaged and normalized to
set the wild-type peaks to 100% (Figure 5), and t tests were
performed to interrogate the difference between wild-type and
cydD data. Peaks that were of significantly lower magnitude in the
cydD data were at 1.92, 2.41, 3.78 and 9.35 ppm, corresponding
to acetate, succinate, mannitol, NAD+ , respectively. Metabolite
peaks that were increased in size for the cydD data were at
2.14 and 3.27 ppm, corresponding to methionine and betaine,
respectively. Acetate, betaine, methionine, NAD+ and succinate
are highlighted in indigo on the cydD metabolic model (Figure 2).
pH is unaffected in a cydD strain
Given that the loss of a functional CydDC transporter results in
the absence of cytochrome bd-type oxidases that contribute to the
proton-motive force, it was of interest to ascertain whether
the transmembrane proton gradient (pH) was perturbed in a
cydD strain. The pH was found to be maintained in a cydD strain,
and internal pH values were all moderately alkaline (Figure 6).
Hence, the energy-conserving cytochrome bo′ quinol oxidase
and NADH dehydrogenase (NDH-1) appear to provide sufficient
proton translocation to avoid acidification of the cytoplasm.
Both cysteine and GSH are required to restore bd-type oxidase
assembly in a cydD mutant
It has previously been demonstrated that exogenous addition of
neither cysteine (0.2–2 mM) nor GSH (0.1–2 mM) [5,6] could
restore the assembly of bd-type quinol oxidases in a cydD
strain, although the addition of both GSH and cysteine was not
performed in tandem. CO-difference spectra of whole cells in
the current study demonstrate for the first time that exogenous
addition of both cysteine (0.5 mM) and GSH (1 mM) is necessary
to restore the assembly of bd-type cytochrome assembly in E.
coli (Figure 7), and confirm previous reports that alone these
reduced thiol-containing compounds cannot complement this
cydD phenotype.
Loss of cydD elicits sensitivity to nitric oxide
Loss of the respiratory oxidase cytochrome bd-I has previously
been shown to elicit sensitivity to NO [36]. Since CydDC is
required for the assembly of bd-type oxidases [1,2], one would
also expect that our cydD strain would be sensitive to NO.
Furthermore, since the reduced thiols exported by CydDC are
capable of interacting with NO and could potentially hamper its
passage into the cell, it was hypothesized that diminished thiol
export in a cydD strain (Figure 1) would lead to an additional
sensitivity to NO beyond that of a mutant lacking only cytochrome
bd-I. NO sensitivity was quantified by measuring growth rates
following the addition of the NO-releasing molecule NOC-12
(Figure 8), which demonstrate that CydDC does indeed provide
protection against NO beyond the contribution to cytochrome bd-I
assembly.
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Figure 4 Differential expression of genes in a cydD strain, under the control of BetI, CysB, FadR, FlhDC, GlcC, HcaR, MhpR, NarP and PurR
The mean fold increase or decrease in individual gene expression in a cydD strain compared to wild-type controls is indicated by the colour scale bar. Functional annotations were taken from the
Ecogene and RegulonDB websites.
DISCUSSION
The initial goal of the current work was to test the hypothesis that
CydDC activity acts to increase the extracellular concentration of
reduced thiols with a corresponding decrease in intracellular thiol
content. Deletion of cydD results in increased reduced thiol in
the growth medium and overexpression of CydDC diminishes the
reduced thiol content of the cytoplasm (Figure 1), allowing both
parts of the hypothesis to be accepted. However, although CydDC
clearly exports reduced thiols, loss of this transporter alone does
not result in an ‘over-reducing’ cytoplasm, presumably due to a
variety of adaptations that deal with redox stress associated with
diminished export of reduced thiol compounds.
To identify the adaptations of cydD cells that combat redox
stress due to loss of CydDC function, a cydD vs. wild-type
microarray study was conducted. The transcriptomic data and
transcription factor modelling are consistent with the hypothesis
that cydD cells exhibit a rebalancing of metabolic flux into the
Krebs cycle in a number of ways: i) protein degradation plays a
major role in carbon flux into the Krebs cycle via succinyl-CoA
and pyruvate, probably enabled by an increased availability of
misfolded protein, ii) fatty acids and glycolate are catabolized
to form acetyl-CoA and pyruvate, respectively. There are also
some interesting adaptations in the cydD cells involved with
nucleotide metabolism and osmoprotection. The gene encoding
the glutaredoxin-like protein NrdH enzyme, an electron donor
for the ribonucleotide reductase NrdEF, is up-regulated in cydD
cells along with nrdE (Figure 2). NrdH is reduced by thioredoxin
reductase (TrxB) and not by glutathione [37], which provides
an alternative means of dNTP production that does not involve
glutathione directly, as is the case for the NrdAB ribonucleotide
reductase (Figure 2). Intriguingly, TrxB is adjacent to cydDC
on the chromosome, which perhaps indicates a co-evolution of
distinct routes for dNTP production. In terms of osmoprotection,
the glycine betaine betAB genes involved in osmotic homoeostasis
[34] are up-regulated in cydD cells (Figures 2–4). It is therefore
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Figure 5 1H NMR analysis of metabolite variations in response to loss of
CydDC
Integrated peak areas for the wild-type data were normalized to 100 % (black bars), and
the magnitudes of the cydD metabolites are expressed as a % of the corresponding
wild-type metabolite (white bars). Student’s t -tests identified metabolite concentrations that
were significantly different between wild-type and cydD cultures at the 95 % (*) and 99 % (**)
levels.
Figure 6 A cydD strain maintains a moderately alkaline pH during
exponential phase
(A) BW25113 () and BW25113-cydD () strains were grown at an initial pH of 7.5. Samples
were taken at various optical densities and the internal and external pH was measured. (B) The
data in panel A are depicted as the pH balance at various optical densities for both strains.
hypothesized that the BetAB system provides glycine-betaine
(i.e. betaine) to alleviate osmotic perturbations elicited by an
accumulation of glutathione and cysteine in cydD cells (Figure 2).
Another notable transcriptional adaptation of energy
metabolism is the up-regulation of the nitrite reductase nap
genes in the cydD strain (Figures 2–4). NapGH is a membrane-
associated complex that can channel electrons from ubiquinol
to the periplasmic NapAB nitrate reductase [29,30]. These
observations are unusual for cells that are grown under
aerobic conditions, since the expression of genes involved in
denitrification are usually only up-regulated under anaerobic
conditions. However, the expression of CydDC has previously
been shown to be under the control of the transcription factors
FNR, NarL and NarP [38], demonstrating that CydDC is co-
Figure 7 Addition of exogenous cysteine and GSH restores cytochrome bd
assembly in cydD cells
Wild-type and cydD strains of E. coli BW25113 were harvested at 40 Klett and CO-difference
spectra were recorded and normalized to give a common Soret peak magnitude. Exogenous
cysteine (0.5 mM) and GSH (1 mM) were added to the growth media where indicated.
Figure 8 Loss of CydDC elicits sensitivity to NO
Strains lacking cytochrome bd-I (cydB) and lacking the CydDC transporter (cydD) were grown
alongside the isogenic wild-type strain and assessed for their ability to grow in the presence of
various concentrations of the NO donor NOC-12. Although both mutant strains exhibit sensitivity
to NO, growth of the cydD strain was impaired to a greater extent compared to the cydB strain
at all concentrations of NOC-12.
regulated with respiratory complexes that perform nitrite/nitrate
reduction. Given that cydD cells do not assemble cytochrome-
bd type ubiquinol oxidases [13] and are therefore deficient in an
electron sink for reduced ubiquinol, these data are consistent with
the hypothesis that electrons from the quinone pool are diverted
away from the absent cytochrome-bd type ubiquinol oxidases
towards the nitrate reductase that is up-regulated in cydD cells
(Figure 2). Furthermore, it is intriguing that genes encoding the nrf
and nir nitrite reductases are also up-regulated, which may provide
a means for the channelling of electrons away from NapAB. In
addition, NapGH has previously been shown to liberate NAD+
that provides a redox-balancing role in E. coli [30], which may
also function as an electron sink during the production of betaine
(Figure 2).
Many of the observed transcriptomic adaptations are a likely
response to reductant-induced perturbations in the activity of
c© 2016 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution License 3.0.
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enzymes involved in energy metabolism, the most obvious
candidate being the only iron–sulfur cluster-containing enzyme
in the Krebs cycle, aconitase. However, kinetic assays on cell
extracts revealed no difference in aconitase activity in wild-
type and cydD cells (Supplementary Figure S1), suggesting
that flux between citrate and isocitrate is not restricted in
cydD cells. However, the formation of thioester-containing CoA
intermediates (acetyl-CoA and succinyl-CoA) is a process that
may be perturbed by elevated GSH/cysteine in the cytoplasm of
cydD cells. Indeed, early work has reported that CoASSG, the
mixed disulfide between glutathione and coenzyme A, is a major
component of the CoA pool in E. coli [39], and that glutathione
deficiency diminishes the levels of CoASSG [40]. Conversely, in
a cydD mutant where glutathione is abundant, it seems probable
that the formation of high levels of CoASSG might restrict the
amount of CoA available for the formation of succinyl-CoA and
acetyl-CoA for energy metabolism, explaining the up-regulation
of pathway enzymes that lead to the synthesis of these metabolites
in a cydD strain (Figure 2).
To provide an independent validation of the model for
adaptations in cydD cells (Figure 2), the analysis of
metabolites via 1H NMR analysis revealed that both betaine
and methionine concentrations were elevated in cydD cells,
which was consistent with the observed transcriptomic changes.
Furthermore, concentrations of acetate, NAD+ , mannitol and
succinate were diminished. It is intuitive to suggest that acetate
levels are depleted to fuel the likely rise in β-oxidation in cydD
cells, and NAD+ is probably depleted during the formation of
high concentrations of betaine in cydD cells (Figure 5), although
it is not clear why mannitol concentrations would be altered. The
diminished succinate levels in cydD cells might reflect a lack of
succinyl-CoA, although this does not explain the observation that
fumarate levels are unaffected in cydD cells (Figure 5).
Although mutation of cydD has previously been shown to
dramatically diminish ubiquinol oxidase activity [2], cydD cells
are able to maintain both a wild-type growth rate and a
stationary phase biomass close to that of wild type. Given
that glycerol metabolism by E. coli produces 3 moles of ATP
(or an energetically equivalent nucleotide) by substrate level
phosphorylation, and one of these is consumed by glycerol kinase,
it therefore seems unlikely that substrate level phosphorylation is
the sole source of ATP generation in the cydD strain. This leads to
the hypothesis that cydD cells maintain a proton-motive force for
the generation of ATP via the membrane-bound F1Fo ATPase. The
similar pH in wild-type and cydD cells (Figure 6) is consistent
with this hypothesis. In addition, elevated protein degradation
could provide an ample supply of the gluconeogenic substrate
pyruvate, which may be converted to glucose for subsequent use
in glycolytic ATP production.
The demonstration that both glutathione and cysteine can
complement for the loss of cytochrome bd-I assembly in a cydD
mutant is the first demonstration that external reductant restores
the incorporation of b- and d-type haems into a cytochrome
complex (Figure 7). This is on one hand unsurprising, as loss
of CydDC had previously been shown to abolish the assembly
of bd-type oxidases in E. coli [1,2], although it is intriguing
that both cysteine and GSH are required for restoration. The
findings reported herein are consistent with previous studies
that demonstrate that neither GSH alone nor cysteine alone can
restore bd-type assembly in a mutant lacking CydDC [5,6]. It has
previously been shown that glutathione is transported to the E. coli
periplasm in the absence of CydDC, suggesting that alternative
mechanisms exist for GSH efflux [41]. However, the current
data indicate that these putative alternative mechanisms do not
provide a sufficient rate of GSH export to maintain the assembly
of bd-type cytochromes, even in the presence of exogenously
added cysteine. Furthermore, loss of CydDC clearly diminishes
the extracytoplasmic reduced thiol content (Figure 1), which is
not compensated for by alternative GSH-export mechanisms.
The additional NO sensitivity of a mutant lacking CydDC
compared to a mutant containing a deletion of the cytochrome
bd-I operon (Figure 8 and Supplementary Figure S2) is consistent
with higher extracytoplasmic reduced thiols in the cydB strain
providing additional protection against NO beyond that supplied
by the cytochrome bd-I oxidase [36]. This is potentially due to the
nitrosylation of these reduced thiols in the periplasm hampering
the diffusion of NO towards cytoplasmic NO targets. Given
that pathogenic strains of E. coli encounter NO from various
sources during colonization of the host, the current work suggests
that CydDC provides an important mechanism to evade this
innate immune response during infection. From an evolutionary
perspective, it is interesting that cydDC is up-regulated at the
transcriptional level by nitrite and nitrate [38], as reduction of
these respiratory electron acceptors can result in the generation of
NO during anaerobic respiration (in E. coli and other commensal
gut bacteria). This regulatory mechanism is consistent with the
hypothesis that CydDC has a role in nitrosative stress tolerance
during infection. Indeed, disruption of cydC in Mycobacterium
tuberculosis results in a decreased survival in mice during the
transition to chronic infection [42], and Brucella abortus was
found to be significantly attenuated in mice when cydC was
disrupted [43].
The current work provides a substantial insight into the
response of E. coli to changing intracellular redox conditions.
The data indicate that cytoplasmic low molecular weight thiols
can diminish the supply of thioester intermediates in energy
metabolism (acetyl- and succinyl-CoA), resulting in protein
degradation and fatty acid β-oxidation to combat this deficiency.
The contribution of CydDC to NO tolerance highlights that the
redox balancing role provided by this ABC transporter may be an
important mechanism for survival during host infection.
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